Australians prescribed medicinal cannabis with very high THC levels, study finds
A study reveals that Australian patients are frequently prescribed medicinal cannabis products with extremely high levels of THC, the psychoactive component. Critics say this prioritizes profit over patient safety, raising concerns about potential side effects and addiction risks. The findings highlight a need for tighter regulation in the growing medicinal cannabis market.